Domov › Intersticijske pljučne bolezni › Arizona
Klinične študije za Intersticijske pljučne bolezni v Arizona
13 študij za Intersticijske pljučne bolezni išče udeležence na lokacijah v Arizona.
Mesta v Arizona
Uradno besedilo študije (angleško)
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA027, Phoenix
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Arizona Heart Rhythm Center, Phoenix
- University of Arizona, Tucson
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT05798923Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- Phoenix, Phoenix
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07473700A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Scottsdale
- GSK Investigational Site, Scottsdale
- GSK Investigational Site, Tucson
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT05878717Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Banner University Medical Center, Phoenix
- Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute, Phoenix
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix
- Arizona Pulmonary Specialists, Ltd., Scottsdale
Vključevanje udeležencevFaza 3
Starost 18–80 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07285655DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Banner Health - University Medical Center Phoenix, Phoenix
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT06388421Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Arizona, Tucson
Vključevanje udeležencevOpazovalna študija
Starost 21 in več · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Arizona Pulmonary Specialists, Phoenix
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Banner University Medical Center Phoenix Lung Institute, Phoenix
- Norton Thoracic Institute, Phoenix
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 13. jul. 2026 · NCT05943535An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Arizona Pulmonary Specialists, Phoenix
Vključevanje udeležencevOpazovalna študija
Starost 18–80 · Vsi spoli · Posodobljeno 26. jun. 2026 · NCT06129240Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
- Mayo Clinic in Arizona, Scottsdale
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 20. mar. 2026 · NCT06751069Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- HonorHealth Research Institute, Scottsdale
Vključevanje udeležencevFaza 2
Starost 40 in več · Vsi spoli · Posodobljeno 12. nov. 2025 · NCT05975983Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.